Skip to content
DefDex

Federal award

LYRA THERAPEUTICS INC

W911NF10C0089

Contract

Obligated and Ceiling

Obligated (net)
$11,488,841.00
Ceiling (potential value, not spending)
$11,488,841.00
Current value
$11,488,841.00
Gross positive obligations
$11,488,841.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
LYRA THERAPEUTICS INC · DK48JGAVNMJ1
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
LYRA THERAPEUTICS INC · DK48JGAVNMJ1
Awarding agency
Department of War · sub-agency 2100 · office W911NF
Funding agency
Department of War · sub-agency 97AE
Product or service (PSC)
AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Industry (NAICS)
541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
PIID
W911NF10C0089
Award type code
D
Actions
9 · Jun 29, 2010 to Dec 18, 2013
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History9

Award actions
DateFYModAction typeObligationCompany in company totals
Dec 18, 2013FY2014P00008M$0.00
—
Jun 27, 2013FY2013P00007M$0.00
—
May 1, 2013FY2013P00006M$0.00
—
Aug 16, 2012FY2012P00005M$0.00
—
Jun 20, 2012FY2012P00004M$0.00
—
Mar 29, 2012FY2012P00003B$4,620,026.00
—
Mar 7, 2011FY2011P00002G$2,774,811.00
—
Oct 7, 2010FY2011P00001M$0.00
—
Jun 29, 2010FY20100—$4,094,004.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.